A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said.
Tag: CureVac GmbH
Rich Countries Signed Away a Chance to Vaccinate the World
Despite warnings, American and European officials gave up leverage that could have guaranteed access for billions of people. That risks prolonging the pandemic.
Where Europe Went Wrong in Its Vaccine Rollout, and Why
While Washington went into business with the drug companies, Europe was more fiscally conservative and trusted the free market.